Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies

Wei-Ting Chen1, Chen-Jee Hong, Ya-Tzu Lin

  • 1Institute of Brain Science, National Yang Ming University, Taipei, Taiwan.

Plos One
|May 5, 2012
PubMed

Insights

A novel amyloid precursor protein (APP) mutation (D7H) linked to early-onset Alzheimer's disease (AD) increases amyloid-beta (Aβ) production and aggregation. This mutation may enhance Aβ

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Familial Alzheimer's disease (AD) is often linked to mutations in the amyloid precursor protein (APP).
  • These mutations typically increase amyloid-beta (Aβ) levels or promote its aggregation, contributing to AD pathology.

Observation:

  • A novel APP mutation, Aβ(D7H), was identified in a Taiwanese family with early-onset AD.
  • Cellular and biochemical analyses were performed to investigate the pathogenicity of this mutation.

Findings:

  • The Aβ(D7H) mutation significantly increased Aβ production and the Aβ42/40 ratio.
  • This mutation resulted in a prolonged Aβ42 oligomer state with enhanced neurotoxicity.
  • Aβ(D7H) showed increased susceptibility to metal ions (Zn(2+), Cu(2+)), promoting aggregation into low molecular weight oligomers.

Implications:

  • The D7H mutation may contribute to AD pathogenesis via a "double punch" mechanism, increasing both Aβ production and aggregation.
  • The N-terminal region of Aβ may play a role in modulating APP processing and Aβ aggregation.
  • This finding suggests a potential genetic link between metal ions (Zn(2+), Cu(2+)) and Alzheimer's disease etiology.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...